The Venture Codex

Participated · Seed · Jun 2026

Tomo is an iMessage-based personal AI that learns users’ goals and motivations, sends reminders and motivation, and adapts by generating personalized interfaces through a companion app. The product integrates with calendars, email, Notion, Google Drive and can join group chats, send reminders, watch videos, edit photos and accept user inputs like bank statements or screen time reports for accountability. In its first 3.5 months from stealth, Tomo gained about 10,000 paying customers and reports users engage around 20 days per month. The company emphasizes automatically building and updating interfaces tailored to individual habits and goals rather than requiring manual configuration. Co-founders Justin Quan and Raymond Chen have prior experience building agentic app platforms and viral consumer products. Tomo’s stated long-term vision is to become the most trusted consumer AI by combining engineering, psychology and anthropology to know when and how to intervene for users.

Led · Equity · Jul 2025

Dash Bio has developed a first-in-industry bioanalysis platform that combines a 24,000-square-foot GLP laboratory, robotics, and a proprietary laboratory operating system to productize assays including ELISA, MSD, qPCR, ddPCR, and LC-MS. The platform emphasizes speed, automation, transparent fixed pricing, and end-to-end digital traceability, returning preclinical sample results in days rather than months. Since launching go-to-market efforts roughly nine months ago, Dash has secured contracts with over 30 customers, including four top-15 global pharmaceutical companies. Financially, the company has raised a total of $47.5 million following its $30 million Series A led by Oak HC/FT. Dash plans to use new funding to scale commercial operations, expand its assay menu and lab capacity, move into new categories, and continue developing its proprietary software. The company was founded by Dave Johnson (CEO), Ander Tallett (COO), and Ely Porter (CSO).